Indigofera tinctoria (C170) with CAS number 84775-63-3 has been scrutinized by the SCCS since 2003. The first SCCS opinion called for “a complete safety dossier on Indigofera tinctoria is required”.
Indigofera tinctoria (C170) with CAS number 84775-63-3 has been scrutinized by the SCCS since 2003. The first SCCS opinion called for “a complete safety dossier on Indigofera tinctoria is required”.
Obelis Academy organized COVID-19 Webinar – Cosmetic on April 29, 2020.
The webinar was especially designed to teach you, step-by-step, how to place on the EU Market Covid-19 related cosmetic products, with a special focus on hand sanitizers (classified as Cosmetics or Biocides).
The aim of this online comprehensive course was to provide the knowledge and train attendees to be able to act as “Person Responsible for Regulatory Compliance” within their organisations under the Medical Device and In-Vitro Diagnostic Regulations (MDR & IVDR).
Interested in The Medical Device Regulations? Read more about Obelis webinars on it.
Fimea, the Finnish Medicines Agency, took over the supervision of medical devices, operators and device trials from Finland’s National Supervisory Authority for Welfare and Health (Valvira).
In the light of the major changes, the transitional compliance period has been exceptionally prolonged after the notification date, i.e. January 10, 2020.
Parallel imports under the MDR, when, who and how:
So which actions do Manufacturers have to take to be MDR COMPLIANT for the EU market?
Read more about it here.
If a “worst-case scenario” was actually to happen, Swiss manufacturers will have to meet third country requirements.
safety test, safety assessment, cosmetics, cosmetic industry, cosmetic compliance, ensure cosmetic compliance, safety of the cosmetic product